Apyx Medical Corp (APYX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 20M 40M 60M Q4 '10: 24.2M Q1 '11: 24.8M Q2 '11: 25.7M Q3 '11: 25.5M Q4 '11: 25.4M Q1 '12: 26M Q2 '12: 26.6M Q3 '12: 27M Q4 '12: 27.7M Q1 '13: 26.6M Q2 '13: 25.2M Q3 '13: 24.4M Q4 '13: 23.7M Q1 '14: 24.4M Q2 '14: 25.3M Q3 '14: 26.3M Q4 '14: 27.7M Q1 '15: 27.3M Q2 '15: 27.7M Q3 '15: 28.7M Q4 '15: 29.5M Q1 '16: 31.2M Q2 '16: 33.2M Q3 '16: 35.4M Q4 '16: 36.6M Q1 '17: 37.2M Q2 '17: 37.7M Q3 '17: 30.3M Q4 '17: 24.5M Q1 '18: 19.5M Q2 '18: 13.4M Q3 '18: 14.4M Q4 '18: 16.6M Q1 '19: 18.8M Q2 '19: 21.8M Q3 '19: 25.7M Q4 '19: 28.2M Q1 '20: 27.6M Q2 '20: 25.2M Q3 '20: 24.6M Q4 '20: 27.7M Q1 '21: 31.4M Q2 '21: 38.3M Q3 '21: 43.2M Q4 '21: 48.5M Q1 '22: 52.4M Q2 '22: 51.4M Q3 '22: 48.7M Q4 '22: 44.5M Q1 '23: 44.2M Q2 '23: 47.4M Q3 '23: 50.3M Q4 '23: 52.3M Q1 '24: 50.5M Q2 '24: 49M Q3 '24: 48.5M Q4 '24: 48.1M Q1 '25: 47.3M Q2 '25: 46.5M Q3 '25: 47.9M Q4 '25: 52.8M Q1 '26: 55.9M Q2 '26: 58.4M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Gross Profit TTM

0 15M 30M 45M Q4 '10: 10M Q1 '11: 10.1M Q2 '11: 10.9M Q3 '11: 10.8M Q4 '11: 10.7M Q1 '12: 11.1M Q2 '12: 10.9M Q3 '12: 11.2M Q4 '12: 11.3M Q1 '13: 10.7M Q2 '13: 10.1M Q3 '13: 9.4M Q4 '13: 9.2M Q1 '14: 9.8M Q2 '14: 9.4M Q3 '14: 9.1M Q4 '14: 9M Q1 '15: 8.9M Q2 '15: 10.2M Q3 '15: 11.5M Q4 '15: 12.6M Q1 '16: 13.2M Q2 '16: 14.8M Q3 '16: 16.6M Q4 '16: 17.9M Q1 '17: 18.8M Q2 '17: 19.2M Q3 '17: 16M Q4 '17: 13.9M Q1 '18: 11.9M Q2 '18: 9.4M Q3 '18: 10M Q4 '18: 10.8M Q1 '19: 12.2M Q2 '19: 14.3M Q3 '19: 17.1M Q4 '19: 19.1M Q1 '20: 18.5M Q2 '20: 15.9M Q3 '20: 15.4M Q4 '20: 17.5M Q1 '21: 20.4M Q2 '21: 25.8M Q3 '21: 29.2M Q4 '21: 33.6M Q1 '22: 36M Q2 '22: 35.3M Q3 '22: 33M Q4 '22: 29.1M Q1 '23: 28.5M Q2 '23: 30.9M Q3 '23: 33.1M Q4 '23: 33.8M Q1 '24: 32.1M Q2 '24: 30.3M Q3 '24: 29.3M Q4 '24: 29.4M Q1 '25: 29.1M Q2 '25: 28.7M Q3 '25: 30M Q4 '25: 33M Q1 '26: 35.3M Q2 '26: 37.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q4 '10: -2.8M Q1 '11: -1.8M Q2 '11: -495K Q3 '11: -132K Q4 '12: 1M Q1 '13: -15K Q2 '13: -1.9M Q3 '13: -2.7M Q4 '13: -3.7M Q1 '14: -2.9M Q2 '14: -3M Q3 '14: -4.9M Q4 '14: -5.8M Q1 '15: -8.2M Q2 '15: -8M Q3 '15: -7.4M Q4 '15: -7M Q1 '16: -6.7M Q2 '16: -5.7M Q3 '16: -4.1M Q4 '16: -11.4M Q1 '17: -11.1M Q2 '17: -11.9M Q3 '17: -14.5M Q4 '17: -9.1M Q1 '18: -10.1M Q2 '18: -11.7M Q3 '18: -11.7M Q4 '18: -14.3M Q1 '19: -17.3M Q2 '19: -18.8M Q3 '19: -20.7M Q4 '19: -20.9M Q1 '20: -22.6M Q2 '20: -24.4M Q3 '20: -24M Q4 '20: -20.1M Q1 '21: -17.3M Q2 '21: -15.2M Q3 '21: -14.8M Q4 '21: -14.4M Q1 '22: -15.6M Q2 '22: -17.5M Q3 '22: -19.3M Q4 '22: -23.6M Q1 '23: -23.3M Q2 '23: -18.6M Q3 '23: -17.4M Q4 '23: -17.3M Q1 '24: -18.3M Q2 '24: -22.6M Q3 '24: -21.6M Q4 '24: -18.8M Q1 '25: -15.3M Q2 '25: -12.3M Q3 '25: -9.5M Q4 '25: -6.4M Q1 '26: -4.3M Q2 '26: -3.5M Q2 '11 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Net Income TTM

-50M -25M 0 25M 50M 75M Q1 '11: -817K Q2 '11: -444K Q3 '11: -385K Q4 '11: 109K Q1 '12: -196K Q2 '12: -473K Q3 '12: -543K Q4 '12: 617K Q1 '13: 21K Q2 '13: -1.2M Q3 '13: -1.6M Q4 '13: -7M Q1 '14: -16.2M Q2 '14: -14.8M Q3 '14: -17.2M Q4 '14: -17.5M Q1 '15: -8.8M Q2 '15: -10.6M Q3 '15: -9.4M Q4 '15: -5.4M Q1 '16: -6.4M Q2 '16: -5.5M Q3 '16: -4.8M Q4 '16: -11.6M Q1 '17: -11.3M Q2 '17: -12.1M Q3 '17: -12.4M Q4 '17: -5.1M Q1 '18: -4.3M Q2 '18: -5.9M Q3 '18: 63.8M Q4 '18: 61.3M Q1 '19: 56.6M Q2 '19: 55.2M Q3 '19: -17.6M Q4 '19: -19.7M Q1 '20: -16.1M Q2 '20: -16.4M Q3 '20: -15.8M Q4 '20: -11.9M Q1 '21: -14.8M Q2 '21: -14.2M Q3 '21: -14.7M Q4 '21: -15.2M Q1 '22: -16.2M Q2 '22: -17.6M Q3 '22: -19.1M Q4 '22: -23.2M Q1 '23: -20.7M Q2 '23: -16.3M Q3 '23: -15.2M Q4 '23: -18.7M Q1 '24: -22.8M Q2 '24: -28.4M Q3 '24: -28.4M Q4 '24: -23.5M Q1 '25: -20M Q2 '25: -17.3M Q3 '25: -14.5M Q4 '25: -11.2M Q1 '26: -9.2M Q2 '26: -8.6M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

0 8M 16M 24M Q4 '10: 14.2M Q1 '11: 14.6M Q2 '11: 14.9M Q3 '11: 14.7M Q4 '11: 14.7M Q1 '12: 14.9M Q2 '12: 15.7M Q3 '12: 15.8M Q4 '12: 16.3M Q1 '13: 15.9M Q2 '13: 15.2M Q3 '13: 14.9M Q4 '13: 14.5M Q1 '14: 14.6M Q2 '14: 15.9M Q3 '14: 17.2M Q4 '14: 18.7M Q1 '15: 18.4M Q2 '15: 17.5M Q3 '15: 17.2M Q4 '15: 17M Q1 '16: 18M Q2 '16: 18.4M Q3 '16: 18.8M Q4 '18: 5.8M Q1 '19: 6.7M Q2 '19: 7.5M Q3 '19: 8.6M Q4 '19: 9.1M Q1 '20: 9.1M Q2 '20: 9.3M Q3 '20: 9.3M Q4 '20: 10.2M Q1 '21: 11M Q2 '21: 12.5M Q3 '21: 14M Q4 '21: 14.9M Q1 '22: 16.4M Q2 '22: 16.1M Q3 '22: 15.7M Q4 '22: 15.4M Q1 '23: 15.7M Q2 '23: 16.6M Q3 '23: 17.2M Q4 '23: 18.6M Q1 '24: 18.3M Q2 '24: 18.7M Q3 '24: 19.2M Q4 '24: 18.7M Q1 '25: 18.2M Q2 '25: 17.8M Q3 '25: 17.9M Q4 '25: 19.8M Q1 '26: 20.6M Q2 '26: 21.3M Q1 '12 Q4 '13 Q3 '15 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q4 '11: 1.9M Q1 '12: 674K Q2 '12: 134K Q3 '12: -94K Q4 '12: 165K Q1 '13: 398K Q2 '13: -1.6M Q3 '13: -1.2M Q4 '13: -2.5M Q1 '14: -3.3M Q2 '14: -2.6M Q3 '14: -2M Q4 '14: -417K Q1 '15: -1.2M Q2 '15: -3.2M Q3 '15: -4.6M Q4 '15: -5.8M Q1 '16: -6.3M Q2 '16: -4M Q3 '16: -3.3M Q4 '16: -2.8M Q1 '17: -3.4M Q2 '17: -4.4M Q3 '17: -5M Q4 '17: -3.7M Q1 '18: -2M Q2 '18: -1.5M Q3 '18: -2.1M Q4 '18: -20.9M Q1 '19: -24.9M Q2 '19: -29.9M Q3 '19: -33.3M Q4 '19: -18.5M Q1 '20: -20.8M Q2 '20: -20.2M Q3 '20: -18.3M Q4 '20: -16.1M Q1 '21: -10.7M Q2 '21: -10.7M Q3 '21: -11.7M Q4 '21: -10.4M Q1 '22: -12.9M Q2 '22: -13.8M Q3 '22: -15.5M Q4 '22: -20.3M Q1 '23: -17.6M Q2 '23: -16.6M Q3 '23: -7.6M Q4 '23: -5.2M Q1 '24: -9.7M Q2 '24: -9.2M Q3 '24: -17.3M Q4 '24: -18M Q1 '25: -12.4M Q2 '25: -9.3M Q3 '25: -8.4M Q4 '25: -8M Q1 '26: -7.9M Q2 '26: -10.1M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q4 '11: 1.4M Q1 '12: -36K Q2 '12: -434K Q3 '12: -626K Q4 '12: -588K Q1 '13: -243K Q2 '13: -2.3M Q3 '13: -1.9M Q4 '13: -3.1M Q1 '14: -3.9M Q2 '14: -3M Q3 '14: -2.5M Q4 '14: -1M Q1 '15: -2M Q2 '15: -4.2M Q3 '15: -5.5M Q4 '16: -3.1M Q1 '17: -3.7M Q2 '17: -4.7M Q3 '17: -5.5M Q4 '17: -4.3M Q1 '18: -2.7M Q2 '18: -2.3M Q3 '18: -2.5M Q4 '18: -21.2M Q1 '19: -25.2M Q2 '19: -30.4M Q3 '19: -34.5M Q4 '19: -19.8M Q1 '20: -22.1M Q2 '20: -21.2M Q3 '20: -18.7M Q4 '20: -16.6M Q1 '21: -11.4M Q2 '21: -11.3M Q3 '21: -12.5M Q4 '21: -11.2M Q1 '22: -13.7M Q2 '22: -15M Q3 '22: -16.7M Q4 '22: -21.3M Q1 '23: -18.5M Q2 '23: -17.2M Q3 '23: -8.1M Q4 '23: -5.8M Q1 '24: -10.2M Q2 '24: -9.8M Q3 '24: -17.9M Q4 '24: -18.8M Q1 '25: -13.2M Q2 '25: -10M Q3 '25: -9.5M Q4 '25: -9.1M Q1 '26: -9M Q2 '26: -11M Q1 '13 Q4 '14 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '10: 17.4K Q3 '10: 17.6M Q1 '11: 17.6K Q2 '11: 17.8M Q3 '11: 17.8M Q1 '12: 17.8M Q2 '12: 17.8K Q3 '12: 17.6K Q1 '13: 17.6K Q2 '13: 17.7K Q3 '13: 17.7K Q1 '14: 17.7K Q2 '14: 21.2M Q3 '14: 17.8M Q1 '15: 20.5M Q2 '15: 24.4K Q3 '15: 27.1K Q1 '16: 27.1M Q2 '16: 27.1M Q3 '16: 27.1M Q1 '17: 30.9M Q2 '17: 30.9M Q3 '17: 31.1M Q1 '18: 32.9M Q2 '18: 32.9M Q3 '18: 34.9M Q2 '20: 34.2M Q3 '20: 34.2M Q1 '21: 34.3M Q2 '21: 34.3M Q3 '21: 34.3M Q1 '22: 34.4M Q2 '22: 34.5M Q3 '22: 34.6M Q1 '23: 34.6M Q2 '23: 34.6M Q3 '23: 34.6M Q1 '24: 34.6M Q2 '24: 34.6M Q3 '24: 34.6M Q1 '25: 40.7M Q2 '25: 40.7M Q3 '25: 40.7M Q1 '26: 43.7M Q2 '26: 43.9M Q1 '11 Q1 '13 Q1 '15 Q1 '17 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-105.00 -70.00 -35.00 0.00 35.00 70.00 105.00 Q4 '10: -0.09 Q1 '12: -0.02 Q3 '16: -0.18 Q4 '16: -0.15 Q1 '17: -0.14 Q2 '17: -0.16 Q3 '17: -0.16 Q4 '17: -0.17 Q1 '18: -0.14 Q2 '19: -98.34 Q3 '19: -100.43 Q4 '19: -0.59 Q1 '20: -0.48 Q2 '20: -0.49 Q3 '20: -0.47 Q4 '20: -0.36 Q1 '21: -0.44 Q2 '21: -0.42 Q3 '21: -0.43 Q4 '21: -0.44 Q1 '22: -0.47 Q2 '22: -0.51 Q3 '22: -0.56 Q4 '22: -0.67 Q1 '23: -0.60 Q2 '23: -0.47 Q3 '23: -0.43 Q4 '23: -0.54 Q1 '24: -0.66 Q2 '24: -0.82 Q3 '24: -0.83 Q4 '24: -0.67 Q1 '25: -0.55 Q2 '25: -0.45 Q3 '25: -0.36 Q4 '25: -0.27 Q1 '26: -0.22 Q2 '26: -0.20 Q3 '16 Q4 '17 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.